Protein corona

Last updated

A protein corona is a dynamic coating of biomolecules, usually proteins, around the surface of a nanoparticle that forms spontaneously in colloidal nanomaterials upon exposure to biological mediums. [1] Protein coronas can form in many different patterns depending on their size, shape, composition, charge, and surface functional groups, and have properties that vary in different environmental factors like temperature, pH, shearing stress, immersed media composition, and exposing time. [2] These coatings are also changeable according to the conditions of the biochemical and physiochemical surface interactions. [1] Types of protein coronas are known to be divided into two categories: “hard” and “soft”. [2] “Hard” coronas have higher-affinity proteins that are irreversibly bonded to the nanoparticle surface, while “soft” coronas have lower-affinity proteins on the nanoparticle surface that are reversibly bound. [2] These reversibly-bound proteins allow for the biomolecules in “soft” protein coronas to be exchanged or detached over time for various applications. [2] This process is governed by the intermolecular protein-nanoparticle and protein-protein interactions that exist within a solution. [2] In "soft" protein coronas, it is common to observe an exchange of proteins at the surface; larger proteins with lower affinities will often aggregate to the surface of the nanoparticle first, and over time, smaller proteins with higher affinities will replace them, "hardening" the corona, known as the Vroman effect. [2]

Contents

Factors affecting formation

It is known that multiple physicochemical and biochemical factors influence the formation and composition of protein coronas. Many previous studies have focused on understanding these processes and how they can be utilized.

Protein composition and concentration

To determine how the protein composition and concentration affects protein coronas, one study incubated silica nanoparticles in plasma medium for 1 hr and observed the formation of the corona. [3] They found that the proteins adsorbed easily to the silica surface and expressed themselves in different patterns depending on the amount of plasma present in the incubated medium. [3] The experiment was run with 3%, 20%, and 80% plasma, and it was discovered that in the case of plasma, where there is a much higher concentration of lower-affinity proteins than high-affinity proteins, the lower-affinity proteins had a tendency to replace the higher-affinity proteins on the surface of the nanoparticle because of their higher abundance within the plasma. [3] From studies like these, it is clear that a protein corona can be altered significantly, depending on the weight and affinity of the biological molecules in a particular medium. [3]

Media exposure

Another major factor that affects protein coronas is exposure time, or the amount of time a nanoparticle coated in proteins is exposed to fluidic media. [4] Since it is well known that instantly upon introduction of a nanoparticle to a biomolecular medium, a protein corona forms on its surface, one study exposed nanoparticles to biological fluids like human plasma and observed how the length of exposure to these mediums can affect the formation of the corona. [4] After only 30 seconds of interaction, almost 300 proteins were detected adsorbing to the nanoparticle surface, and a majority of those molecules had low affinity (pharmacology) and a large molecular weight. [4] After 1 minute or more of exposure, different protein corona patterns were observed, and of the proteins detected, most of them had a higher affinity and smaller molecular weight, consistent with the Vroman effect. [4] Thus, the length of the exposure time of the nanoparticle to biological fluid can greatly alter the composition and patterns of the protein corona.

In addition to exposure time is the factor of shearing forces. In the past, researchers studied protein-nanoparticle interactions under very static conditions so that variables could be easily controlled. However, these conditions are not very representative of the conditions of the human body where nanoparticles will generally be exposed to shearing stresses and hydrodynamic fluid conditions. [5] Thus, experiments that accounted for fluidic conditions were necessary to understand how protein coronas would endure in the human body. One study found that fluidic flow increased the biodiversity of the protein corona and altered its shape due to the shearing forces present in the environment. [5] Because both of these factors have implications in the functionalization of protein corona nanoparticles, these observations proved the importance of studying protein coronas in the presence of fluidic conditions.

Temperature

Temperature can also greatly affect protein-nanoparticle interactions. A study performed on Cu nanoparticles showed that as the ambient temperature of the nanoparticles was increased from 15 °C, 27 °C, and 37 °C to 42 °C, the amount of protein adsorbed to the nanoparticle surface also increased. [6] This finding was especially interesting in the effort to utilize protein coronas to treat illnesses, because in introducing these particles into the human body, they will have to exist and function at high temperatures. In feverish individuals, their altered body temperature may potentially change the biodistribution and bio-availability of the nanoparticles. [6] Thus, it is important for researchers to account for temperature effects on protein coronas. [6]

pH effects

The environmental pH can also affect protein corona formation. It is known that pH is an important factor to be considered when studying the properties and functionality of proteins. pH can alter protein binding affinity in protein-nanoparticle interactions, thus modifying the adsorbed protein pattern at the surface of the nanoparticle. [7] [8] If used for drug delivery methods, the nanoparticles will have to undergo multiple different pH changes in the cellular uptake pathway like blood (neutral pH), exposure media (pH 6.9-7.4), intracellular fluid (pH 6.8), and lysosomes (pH 4.5-5) and be able to keep its corona intact and functional. [7] [8] Cancer tumors especially are known to induce acidic microenvironments as well as contain certain types of proteins that are capable of modifying the protein corona around nanoparticles which can greatly alter the body’s therapeutic response to drug molecules. [7]

Nanoparticle composition

Lastly, the composition of the nanoparticle itself can affect the protein corona formation at its surface. Differences in the hydrophilic or hydrophobic nature of the nanoparticle material can determine the amount of proteins in the corona. [9] Usually, proteins adsorb more easily to hydrophobic materials than hydrophilic materials. [9] As a result, hydrophobic nanoparticles are more likely to induce particle aggregation and higher opsonization in the human body, which can decrease systemic circulation time in the blood. [9]

Additionally, to aid in formation and solubility, nanoparticles often have ligands and functional groups on their surfaces that act like “fingerprints”. [9] Protein fingerprints refer to the ability to differentiate or identify proteins using ligands and other methods. [9] These fingerprints allow for nanoparticles to be tailored compositionally to adsorb specific proteins to their surfaces. [9] Nanoparticle surface roughness may also play a role in protein corona formation, since one study found that a rough nanoparticle surface can minimize repulsive interactions between the nanoparticle and parts of the binding proteins, which increases the amount of proteins adsorbed. [10]

Applications

Drug delivery

Protein coronas can be utilized for a number of different functions, the main one being drug delivery. The corona that forms when nanoparticles come in contact with biological fluid has long been investigated for its potential to deliver important drug molecules or proteins to sites of need within the human body. [2] Nanoparticles are known to have high drug-loading efficiency as well as the ability to easily pass through biological barriers due to their nano scalability. [11] [12] Their composition tunability allows for their toxicity to be controlled, and they can be modified to contain diverse sets of functional groups that can perform specific activities. [11] [12] These qualities of nanoparticles make them ideal for drug delivery capabilities.

A major area of study within the sphere of protein corona drug delivery, is the study of the circulation time of nanoparticles in the body. In order to optimize the effectiveness of a drug, specifying the location where it is delivered and how long it stays there can be extremely useful. [13] Often, macrophages within the blood will detect the presence of the nanoparticles and immediately work to eliminate them from the body. [13] [14] This is not always a good thing from the perspective of drug delivery, and thus studies were performed to prolong circulation time. It was found that when opsonins, like fibrinogen, are numerous in the protein corona, the proteins tend to induce macrophage recognition and subsequent consumption of nanoparticles. [13] Conversely, when the corona is saturated with dysopsonins, like albumin, the macrophages show decreased recognition of the particles and thus, circulation time of the particles is greatly increased. [13] This technique is loosely referred to as the "stealth effect". [13] By tailoring the contents of the protein corona, the length of time a nanoparticle stays in your body can be controlled.

As mentioned previously, nanoparticles can be grown with particular functional groups on their surfaces that induce chemoselectivity. Functional biomolecules like transferrin, insulin, and folic acid are commonly used in cancer-targeting drug delivery systems. [15] Other smaller molecules like anhydride, amine, carboxyl, and thiol can be used to direct nanoparticles to high cellular association with endothelial cells, pancreatic cells, and activated human macrophages. [15] Certain apolipoproteins, such as Apo E, ApoA1, and ApoB-100, could potentially functionalize nanoparticles to target the nervous system. [16] [17]

Another more pressing problem with nanoparticle drug delivery is the tendency for nanoparticles to accumulate at the target site or in various organs, which can become toxic. [14] It is known that the size of nanoparticles dictates their distribution within the body, meaning that nanoparticles with different sizes will tend to accumulate in certain organs. [18] Therefore, size is a very important control factor when considering nanoparticle distribution and accumulation at target sites during drug delivery. [18]

Related Research Articles

<span class="mw-page-title-main">Colloidal gold</span> Suspension of gold nanoparticles in a liquid

Colloidal gold is a sol or colloidal suspension of nanoparticles of gold in a fluid, usually water. The colloid is coloured usually either wine red or blue-purple . Due to their optical, electronic, and molecular-recognition properties, gold nanoparticles are the subject of substantial research, with many potential or promised applications in a wide variety of areas, including electron microscopy, electronics, nanotechnology, materials science, and biomedicine.

<span class="mw-page-title-main">Molecular imprinting</span> Technique in polymer chemistry

Molecular imprinting is a technique to create template-shaped cavities in polymer matrices with predetermined selectivity and high affinity. This technique is based on the system used by enzymes for substrate recognition, which is called the "lock and key" model. The active binding site of an enzyme has a shape specific to a substrate. Substrates with a complementary shape to the binding site selectively bind to the enzyme; alternative shapes that do not fit the binding site are not recognized.

<span class="mw-page-title-main">Foreign body reaction</span> Bodily response to the presence of a foreign object

A foreign body reaction (FBR) is a typical tissue response to a foreign body within biological tissue. It usually includes the formation of a foreign body granuloma. Tissue-encapsulation of an implant is an example, as is inflammation around a splinter. Foreign body granuloma formation consists of protein adsorption, macrophages, multinucleated foreign body giant cells, fibroblasts, and angiogenesis. It has also been proposed that the mechanical property of the interface between an implant and its surrounding tissues is critical for the host response.

The Vroman effect, named after Leo Vroman, describes the process of competitive protein adsorption to a surface by blood serum proteins. The highest mobility proteins generally arrive first and are later replaced by less mobile proteins that have a higher affinity for the surface. The order of protein adsorption also depends on the molecular weight of the species adsorbing. Typically, low molecular weight proteins are displaced by high molecular weight protein while the opposite, high molecular weight being displaced by low molecular weight, does not occur. A typical example of this occurs when fibrinogen displaces earlier adsorbed proteins on a biopolymer surface and is later replaced by high molecular weight kininogen. The process is delayed in narrow spaces and on hydrophobic surfaces, fibrinogen is usually not displaced. Under stagnant conditions initial protein deposition takes place in the sequence: albumin; globulin; fibrinogen; fibronectin; factor XII, and HMWK.

Magnetic nanoparticles (MNPs) are a class of nanoparticle that can be manipulated using magnetic fields. Such particles commonly consist of two components, a magnetic material, often iron, nickel and cobalt, and a chemical component that has functionality. While nanoparticles are smaller than 1 micrometer in diameter, the larger microbeads are 0.5–500 micrometer in diameter. Magnetic nanoparticle clusters that are composed of a number of individual magnetic nanoparticles are known as magnetic nanobeads with a diameter of 50–200 nanometers. Magnetic nanoparticle clusters are a basis for their further magnetic assembly into magnetic nanochains. The magnetic nanoparticles have been the focus of much research recently because they possess attractive properties which could see potential use in catalysis including nanomaterial-based catalysts, biomedicine and tissue specific targeting, magnetically tunable colloidal photonic crystals, microfluidics, magnetic resonance imaging, magnetic particle imaging, data storage, environmental remediation, nanofluids, optical filters, defect sensor, magnetic cooling and cation sensors.

A nanogel is a polymer-based, crosslinked hydrogel particle on the sub-micron scale. These complex networks of polymers present a unique opportunity in the field of drug delivery at the intersection of nanoparticles and hydrogel synthesis. Nanogels can be natural, synthetic, or a combination of the two and have a high degree of tunability in terms of their size, shape, surface functionalization, and degradation mechanisms. Given these inherent characteristics in addition to their biocompatibility and capacity to encapsulate small drugs and molecules, nanogels are a promising strategy to treat disease and dysfunction by serving as delivery vehicles capable of navigating across challenging physiological barriers within the body. 

<span class="mw-page-title-main">Silver nanoparticle</span> Ultrafine particles of silver between 1 nm and 100 nm in size

Silver nanoparticles are nanoparticles of silver of between 1 nm and 100 nm in size. While frequently described as being 'silver' some are composed of a large percentage of silver oxide due to their large ratio of surface to bulk silver atoms. Numerous shapes of nanoparticles can be constructed depending on the application at hand. Commonly used silver nanoparticles are spherical, but diamond, octagonal, and thin sheets are also common.

<span class="mw-page-title-main">Nanoparticle–biomolecule conjugate</span> Tailored macromolecule with covalently-bonded bio-active substances targeting specific tissues

A nanoparticle–biomolecule conjugate is a nanoparticle with biomolecules attached to its surface. Nanoparticles are minuscule particles, typically measured in nanometers (nm), that are used in nanobiotechnology to explore the functions of biomolecules. Properties of the ultrafine particles are characterized by the components on their surfaces more so than larger structures, such as cells, due to large surface area-to-volume ratios. Large surface area-to-volume-ratios of nanoparticles optimize the potential for interactions with biomolecules.

Adsorption is the accumulation and adhesion of molecules, atoms, ions, or larger particles to a surface, but without surface penetration occurring. The adsorption of larger biomolecules such as proteins is of high physiological relevance, and as such they adsorb with different mechanisms than their molecular or atomic analogs. Some of the major driving forces behind protein adsorption include: surface energy, intermolecular forces, hydrophobicity, and ionic or electrostatic interaction. By knowing how these factors affect protein adsorption, they can then be manipulated by machining, alloying, and other engineering techniques to select for the most optimal performance in biomedical or physiological applications.

<span class="mw-page-title-main">Surface modification of biomaterials with proteins</span>

Biomaterials are materials that are used in contact with biological systems. Biocompatibility and applicability of surface modification with current uses of metallic, polymeric and ceramic biomaterials allow alteration of properties to enhance performance in a biological environment while retaining bulk properties of the desired device.

<span class="mw-page-title-main">Bovine submaxillary mucin coatings</span> Surface treatment for biomaterials

Bovine submaxillary mucin (BSM) coatings are a surface treatment provided to biomaterials intended to reduce the growth of disadvantageous bacteria and fungi such as S. epidermidis, E. coli, and Candida albicans. BSM is a substance extracted from the fresh salivary glands of cows. It exhibits unique physical properties, such as high molecular weight and amphiphilicity, that allow it to be used for many biomedical applications.

Nanoparticles for drug delivery to the brain is a method for transporting drug molecules across the blood–brain barrier (BBB) using nanoparticles. These drugs cross the BBB and deliver pharmaceuticals to the brain for therapeutic treatment of neurological disorders. These disorders include Parkinson's disease, Alzheimer's disease, schizophrenia, depression, and brain tumors. Part of the difficulty in finding cures for these central nervous system (CNS) disorders is that there is yet no truly efficient delivery method for drugs to cross the BBB. Antibiotics, antineoplastic agents, and a variety of CNS-active drugs, especially neuropeptides, are a few examples of molecules that cannot pass the BBB alone. With the aid of nanoparticle delivery systems, however, studies have shown that some drugs can now cross the BBB, and even exhibit lower toxicity and decrease adverse effects throughout the body. Toxicity is an important concept for pharmacology because high toxicity levels in the body could be detrimental to the patient by affecting other organs and disrupting their function. Further, the BBB is not the only physiological barrier for drug delivery to the brain. Other biological factors influence how drugs are transported throughout the body and how they target specific locations for action. Some of these pathophysiological factors include blood flow alterations, edema and increased intracranial pressure, metabolic perturbations, and altered gene expression and protein synthesis. Though there exist many obstacles that make developing a robust delivery system difficult, nanoparticles provide a promising mechanism for drug transport to the CNS.

Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.

<span class="mw-page-title-main">Polymer-protein hybrid</span> Nanostructures of protein-polymer conjugates

Polymer-protein hybrids are a class of nanostructure composed of protein-polymer conjugates. The protein component generally gives the advantages of biocompatibility and biodegradability, as many proteins are produced naturally by the body and are therefore well tolerated and metabolized. Although proteins are used as targeted therapy drugs, the main limitations—the lack of stability and insufficient circulation times still remain. Therefore, protein-polymer conjugates have been investigated to further enhance pharmacologic behavior and stability. By adjusting the chemical structure of the protein-polymer conjugates, polymer-protein particles with unique structures and functions, such as stimulus responsiveness, enrichment in specific tissue types, and enzyme activity, can be synthesized. Polymer-protein particles have been the focus of much research recently because they possess potential uses including bioseparations, imaging, biosensing, gene and drug delivery.

<span class="mw-page-title-main">Polystyrene (drug delivery)</span> Polystyrene in drug delivery

Polystyrene is a synthetic hydrocarbon polymer that is widely adaptive and can be used for a variety of purposes in drug delivery. These methods include polystyrene microspheres, nanoparticles, and solid foams. In the biomedical engineering field, these methods assist researchers in drug delivery, diagnostics, and imaging strategies.

Protein nanotechnology is a burgeoning field of research that integrates the diverse physicochemical properties of proteins with nanoscale technology. This field assimilated into pharmaceutical research to give rise to a new classification of nanoparticles termed protein nanoparticles (PNPs). PNPs garnered significant interest due to their favorable pharmacokinetic properties such as high biocompatibility, biodegradability, and low toxicity Together, these characteristics have the potential to overcome the challenges encountered with synthetic NPs drug delivery strategies. These existing challenges including low bioavailability, a slow excretion rate, high toxicity, and a costly manufacturing process, will open the door to considerable therapeutic advancements within oncology, theranostics, and clinical translational research.

<span class="mw-page-title-main">Intracellular delivery</span> Scientific research area

Intracellular delivery is the process of introducing external materials into living cells. Materials that are delivered into cells include nucleic acids, proteins, peptides, impermeable small molecules, synthetic nanomaterials, organelles, and micron-scale tracers, devices and objects. Such molecules and materials can be used to investigate cellular behavior, engineer cell operations or correct a pathological function.

Selective organ targeting (SORT) is a novel approach in the field of targeted drug delivery that systematically engineers multiple classes of lipid nanoparticles (LNPs) to enable targeted delivery of therapeutics to specific organs in the body. The SORT molecule alters tissue tropism by adjusting the composition and physical characteristics of the nanoparticle. Adding a permanently cationic lipid, a permanently anionic lipid, or ionizable amino lipid increases delivery to the lung, spleen, and liver, respectively. SORT LNPs utilize SORT molecules to accurately tune and mediate gene delivery and editing, resulting in predictable and manageable protein synthesis from mRNA in particular organ(s), which can potentially improve the efficacy of drugs while reducing side effects.

<span class="mw-page-title-main">Aquasome</span> Drug delivery system

Aquasomes are self-assembling nanoparticle drug carrier systems composed of three layers: a ceramic core, an oligomer coat, and a loaded biochemically active molecule. Aquasomes are utilized for targeted drug delivery to achieve specific therapeutic effects, and are biocompatible, biodegradable, and stable. Due to their structure, aquasomes are capable of delivering several types of substrates, and can be used for applications such as delivery of antigens, insulin, and hemoglobin.

<span class="mw-page-title-main">Magnetic nanoparticles in drug delivery</span> Various aspects about the use of magnetic nanoparticle use in drug delivery

Magnetic nanoparticle drug delivery is the use of external or internal magnets to increase the accumulation of therapeutic elements contained in nanoparticles to fight pathologies in specific parts of the body. It has been applied in cancer treatments, cardiovascular diseases, and diabetes. Scientific researches revealed that magnetic drug delivery can be made increasingly useful in clinical settings.

References

  1. 1 2 Turner, J. G.; Murphy, C. J. (2021). "How Do Proteins Associate with Nanoscale Metal–Organic Framework Surfaces?". Langmuir. 37 (32): 9910–9919. doi:10.1021/acs.langmuir.1c01664. PMID   34343005. S2CID   236914115.
  2. 1 2 3 4 5 6 7 Nguyen, V. H.; Lee, B.-J. (2017). "Protein Corona: A New Approach for Nanomedicine Design". Int. J. Nanomed. 12: 3137–3151. doi: 10.2147/IJN.S129300 . PMC   5402904 . PMID   28458536.
  3. 1 2 3 4 Monopoli, M. P.; Walczyk, D.; Campbell, A.; Elia, G.; Lynch, I.; Bombelli, F. B.; Dawson, K. A. (2011). "Physical-Chemical Aspects of Protein Corona: Relevance to in Vitro and in Vivo Biological Impacts of Nanoparticles". J. Am. Chem. Soc. 133 (8): 2525–2534. doi:10.1021/ja107583h. PMID   21288025.
  4. 1 2 3 4 Maiorano, G.; Sabella, S.; Sorce, B. (2015). "Tailoring the stealth properties of biocompatible polysaccharide nanocontainers". Biomaterials. 49: 125–134. doi:10.1016/j.biomaterials.2015.01.042. PMID   25725561.
  5. 1 2 Palchetti, S.; Colapicchioni, V.; Digiacomo, L (2016). "The protein corona of circulating PEGylated liposomes". Biochim Biophys Acta. 1858 (2): 189–196. doi:10.1016/j.bbamem.2015.11.012. PMID   26607013.
  6. 1 2 3 Bhogale, A.; Patel, N.; Mariam, J.; Dongre, P. M.; Miotello, A.; Kothari, D. C. (2014). "Comprehensive Studies on the Interaction of Copper Nanoparticles with Bovine Serum Albumin Using Various Spectroscopies". Colloids Surf. B. 113: 276–284. doi:10.1016/j.colsurfb.2013.09.021. PMID   24121071.
  7. 1 2 3 O'Brien, J.; Shea, K. J. (2016). "Tuning the Protein Corona of Hydrogel Nanoparticles: The Synthesis of Abiotic Protein and Peptide Affinity Reagents". Acc. Chem. Res. 49 (6): 1200–1210. doi:10.1021/acs.accounts.6b00125. PMID   27254382.
  8. 1 2 Ritz, S.; Schottler, S.; Kotman, N.; Baier, G.; Musyanovych, A.; Kuharev, J.; Landfester, K.; Schild, H.; Jahn, O.; Tenzer, N.; Mailander, V. (2015). "Protein Corona of Nanoparticles: Distinct Proteins Regulate the Cellular Uptake". Biomacromolecules. 16 (4): 1311–1321. doi:10.1021/acs.biomac.5b00108. PMID   25794196.
  9. 1 2 3 4 5 6 Mahmoudi, M.; Lynch, I.; Ejtehadi, M. R.; Monopoli, M. P.; Bombelli, F. B.; Laurent, S. (2011). "Protein-Nanoparticle Interactions: Opportunities and Challenges". Chem. Rev. 111 (9): 5610–5637. doi:10.1021/cr100440g. PMID   21688848.
  10. ↑ Rampado, R.; Crotti, S.; Caliceti, P.; Pucciarelli, S.; Agostini, M. (2020). "Recent Advances in Understanding the Protein Corona of Nanoparticles and in the Formulation of "Stealthy" Nanomaterials". Front. Bioeng. Biotechnol. 8: 166. doi: 10.3389/fbioe.2020.00166 . PMC   7145938 . PMID   32309278.
  11. 1 2 Peng, Q.; Zhang, S.; Yang, Q. (2013). "Preformed albumin corona, a protective coating for nanoparticles based drug delivery system". Biomaterials. 34 (33): 8521–8530. doi:10.1016/j.biomaterials.2013.07.102. PMID   23932500.
  12. 1 2 Aggarwal, P.; Hall, J. B.; McLeland, C. B.; Dobrovolskaia, M. A.; McNeil, S. E. (2009). "Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy". Adv Drug Deliv Rev. 61 (6): 428–437. doi:10.1016/j.addr.2009.03.009. PMC   3683962 . PMID   19376175.
  13. 1 2 3 4 5 Kang, B.; Okweika, P.; Schottler, S.; Seifert, O.; Kontermann, R.; Pfizenmaier, K.; Musyanovych, A.; Meyer, R.; Diken, M.; Sahin, U.; Mailander, L.; Wurm, F.; Landfester, K. (2015). "Tailoring the stealth properties of biocompatible polysaccharide nanocontainers". Biomaterials. 10.1016/j.biomaterials.2015.01.042: 125–134. doi:10.1016/j.biomaterials.2015.01.042. PMID   25725561.
  14. 1 2 Wang, Q.; Sun, Y.; Zhang, Z.; Duan, Y (2015). "Targeted Polymeric Therapeutic Nanoparticles: Design and Interactions with Hepatocellular Carcinoma". Biomaterials. 56: 229–240. doi:10.1016/j.biomaterials.2015.03.050. PMID   25934295.
  15. 1 2 Weissleder, R.; Kelly, K.; Sun, E. Y.; Shtatland, T.; Josephson, L. (2005). "Cell-specific targeting of nanoparticles by multivalent attachment of small molecules". Nat. Biotechnol. 23 (11): 1418–1423. doi:10.1038/nbt1159. PMID   16244656. S2CID   19404515.
  16. ↑ Zensi, A.; Begely, D.; Pontikis, C. (2009). "Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones". J Control Release. 137 (1): 78–86. doi:10.1016/j.jconrel.2009.03.002. PMID   19285109.
  17. ↑ Kreuter, J.; Hekmatara, T.; Dreis, S.; Vogel, T.; Gelperina, S.; Langer, K. (2007). "Covalent attachment of apolipoprotein AI and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain". J Control Release. 118 (1): 54–58. doi:10.1016/j.jconrel.2006.12.012. PMID   17250920.
  18. 1 2 Gaumet, M.; Vargas, A.; Gurny, R.; Delie, F. (2008). "Nanoparticles for Drug Delivery: The Need for Precision in Reporting Particle Size Parameters". Eur. J. Pharm. Biopharm. Off. J. Arbeitsgemeinschaft Pharm. Verfahrenstechnik EV. 69 (1): 1–9. doi:10.1016/j.ejpb.2007.08.001. PMID   17826969.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.